German China

Germany: Biopharmaceuticals Sartorius Stedim Biotech Wins Frost & Sullivan Award

Editor: MA Alexander Stark

Sartorius Stedim Biotech (SSB) received Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services.

Related Vendor

Sartorius Stedim Biotech received the Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services.
Sartorius Stedim Biotech received the Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services.
(Source: Sartorius Stedim Biotech)

Goetting/Germany and Glasgow/UK — Presented at the Frost & Sullivan ceremony in London, UK, this award recognizes the product and service combination and customer satisfaction provided by Sartorius Stedim Bio Outsource, SSB’s subsidiary based in Glasgow.

The annual Frost & Sullivan Excellence in Best Practices Awards recognizes companies, processes, strategies, and executives that have achieved world-class performance within their industries. “Sartorius Stedim Bio Outsource cultivates transparent relationships with business partners to enhance the overall service experience and customer satisfaction,” stated Norma Vela-Roch, Best Practices Analyst at Frost & Sullivan.

Sartorius Stedim Bio Outsource navigates biopharmaceutical manufacturers through the complexities of the drug development cycle and enables them to make informed data-driven decisions. With laboratories in the UK and US, (Glasgow and Boston), the Contract Testing Organization offers a broad portfolio of bioanalytical services and off-the-shelf bioassays. It pioneered testing services for biosimilar drugs. The company’s expert scientists have worked with over 50 biosimilar developers across 12 countries, totaling 230 biosimilar projects. The integrated service to support biosimilar development includes cell line development, cell bank characterization and manufacture, and all associated biological and physicochemical analysis.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:44972595)